Pillstats
Rx only · Injection · Intravenous

Docetaxel Anhydrous

Brands: Docetaxel · Docetaxel Anhydrous

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)72962
US makers1 labelers
Packages2
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

Only one quarter on record so far — the trend line fills in as more quarters load.

22
Rx · 2026 Q1
352
Units dispensed
1
Quarters · since 2026 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Sagent Pharmaceuticalsunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • May 28, 2024
    RECALLRecall (Class I): Docetaxel Injection, USP, 80 mg per 8 mL (10 mg per mL), 1 x 8 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuti…

    Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product. — Recalling firm: Sagent Pharmaceuticals — Nationwide within the USA.

  • May 28, 2024
    RECALLRecall (Class I): Docetaxel Injection, USP, 160 mg per 16 mL (10 mg per mL), 1 x 16 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmace…

    Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product. — Recalling firm: Sagent Pharmaceuticals — Nationwide within the USA.